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Introduction 
Infection is the most serious complication following 
prosthetic aortoiliofemoral bypass graft surgery. It may 
result in the patient's death or major amputation in a 
high percentage of cases. 1-s Over the last few years, 
various preoperative and postoperative preventive 
measures have been devised. Better preoperative pre- 
paration of candidates for aortoiliac surgery, moni- 
toring the strictest aseptic conditions throughout the 
operation and antibiotic treatment, have contributed 
to improving the results. The infection of an aortic 
prosthesis till remains a serious problem (0.8-6%), 
burdened with a surgical mortality rate ranging from 
10 to 25% and an amputation rate between 15 and 
20%, according to the various therapeutical strat- 
egies. 6-9 This paper reviews the results of total graft 
excision and extra-anatomic bypass reported in the 
literature and compares this with our own experience. 
cases. The aortoenteric fistula procedure was per- 
formed for a true fistula in two cases and for a para- 
prosthetic fistula with duodenal erosion in 11 cases. 
Preoperative diagnosis was made on the basis of endo- 
scopic examination (five cases), computed tomography 
(CT)-scan (three cases) and fistulography (one case). 
Exploratory laparotomy was used in one case for 
the purposes of diagnosis. When the diagnosis was 
ascertained, an axillobifemoral graft, followed by lap- 
arotomy with prosthetic excision and gastrointestinal 
suture, was performed. In four cases, for which dia- 
gnosis was not sure, laparotomy was performed first, 
followed by an axillobifemoral graft after temporary 
closure of the abdomen; withdrawal of the prosthesis 
was performed in a third stage. Postoperative death 
due to rupture of the aortic stump occurred at 15 days, 
12, 14 and 21 months later. Follow-up for the remaining 
patients ranged from 4 to 12 years (mean value: 8 
years) (Table 1). 
Patients and Results 
Our series, surveyed between 1980 and 1995, included 
20 patients ubmitted to extra-anatomical bypass graft 
surgery due to secondary aortoduodenal fistula (13 
cases) or to infection of an aortobifemoral prosthesis 
(7 cases). All patients were male; the mean age was 
67 (range : 43-76 years). 
Aortoenteric ~'stulae 
The 13 patients with aortoenteric fistulae had been 
operated on an average 4.5 years previously (range 3 
months to 14 years). The arterial esion was stenotic 
disease in eight cases and aortoiliac aneurysm in five 
Aortobifemoral infection 
The seven patients with isolated sepsis had been op- 
erated on average 28 months previously (12 days to 3 
years). In six cases the lesion was stenotic disease and 
in two cases an aortic aneurysm. Escherichia coli was 
revealed in one case and staphylococci in six cases. 
Preoperative diagnosis was made in five patients fol- 
lowing infection of the femoral triangle with associated 
septicaemia, haemorrhage in two cases and sep- 
ticaemia in two cases. CT scanning was always helpful 
in confirming diagnosis; indium scintigraphy was also 
used and was positive in three cases. 
Management was variable. In three cases out of 
seven axillobifemoral graft outside the femoral triangle 
was performed prior to excision of the infected pros- 
thetic graft. In four cases, excision was performed first 
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Table 1. Aortoenteric f istulae - 13 patients male. 
Age Arterial Symptoms Emergency Procedure Results 
disease 
59 Stenosis Sepsis No Axillo-fem. 'BP 1 year death 
Prosthesis haemorrhage 
ablation 
70 Stenosis Sepsis Yes idem 15 days death 
haemorrhage 
66 Stenosis Haemorrhage no idem 10 years alive 
Sepsis 
63 Stenosis Haemorrhage Yes 
64 Aneurysm Haemorrhage Yes 
76 Aneurysm Haemorrhage Yes 
50 Stenosis Haemorrhage No 
58 Aneurysm Haemorrhage Yes 
68 Stenosis Sepsis No 
60 Aneurysm Haemorrhage Yes 
57 Aneurysm Haemorrhage 
73 Stenosis Haemorrhage 
73 Aneurysm Sepsis 
No 
No 
No 
Laparotomy 11 years death 
A.F.B.P unknown 
Prosthesis 
ablation 
idem 12 years alive 
A.F.B.P 6 years alive 
Prosthesis 
ablation 
idem 9 years alive 
A.F.B.P. occluded 
idem 4 years alive 
idem 14 months death 
haemorrhage 
idem 5 years alive 
aorto-B.F.B.P 
(14 m) 
Laparotomy 5 years alive 
A.F.B.P. Aorto-B.F B.P 
Prosthesis 
ablation 
A.F.B.P 
Prosthesis 
ablation 
Laparotomy 
A.F.B.P 
Prosthesis 
ablation 
2 years death 
haemorrhage 
9 years death 
Other cause 
and restricted to one branch of the prosthesis in three 
cases, without reconstruction i  two cases and with 
obturator bypass in one case; in one further case, 
excision was followed by an aortobifemoral graft and 
bypass from the thoracic aorta to the femoral arteries. 
In this series, three immediate deaths were recorded, 
one death occured 1 year later due to severe gastro- 
intestinal haemorrhage and four patients are still alive 
with a fol low-up of 4 years (Table 2). 
Discussion 
Surgical treatment of an infected aortic prosthetic graft 
still remains a difficult problem to solve even for the 
most experienced vascular surgeons. There are a series 
of therapeutical options for the treatment of this serious 
complication, ranging from conservative management  
by treating the prosthetic graft with antibiotics and 
local irrigation of antiseptics in moderate cases, to total 
prosthetic graft excision without vascular re- 
construction of the limbs if the resulting degree of 
ischaemia is acceptable. 11 26 
Although treating prosthetic infection by in situ 
replacement with a fresh prosthesis or an arterial 
allograft has proved to be extremely advantage- 
13 14 17 27 31 l/ , ,  ous, ' ' ' - the standard surgical treatment com- 
prising ablation of the prosthesis and extra-anatomical 
bypass is still widely used in cases of early or dis- 
seminated infection, or because of the emergency situ- 
ation that some signs of prosthetic graft infection may 
lead to, with septic rupture of the anastomosis and 
in cases of gastrointestinal haemorrhage. It is also 
important o be familiar with this technique because 
of the difficulties in finding and preserving arterial 
allografts.13,17,gl 
The treatment of prosthetic infection by total excision 
of the prosthetic graft and extra-anatomic vascular 
reconstruction of the lower limbs does, however, incur 
a high rate of mortality (14-50%) and a high rate 
of amputat ion (25-70%). 24'32'35 This type of operation 
includes complete excision of the infected prosthetic 
graft and the contaminated retroperitoneal tissue, as 
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Table 2. Aortobi femoral  prosthesis infection - seven patients male. 
Age Arterial Symptoms Emergency Procedure Results 
disease 
60 Stenosis Sepsis no A.B.F.B.P 1 year death 
Prosthetic haemorrhage 
ablation 
75 Aneurysm Sepsis - A.B.F.B.P 10 days death 
Haemorrhage Prosthesis Septicemia 
ablation 
68 Stenosis Septicaemia - Prosthesis 12 days death 
ablation (1) 
Transobturator BP Septicaemia 
58 Stenosis Sepsis - Prosthesis 1 year 
ablation (1) Ax.Fem. B.P 
Haemorrhage No reconstruction 4 years alive 
43 Stenosis Sepsis - Prosthesis 3 years alive 
ablation 
A.B.E B.P. 
72 Aneurysm Sepsis - Prosthesis 1 year alive 
ablation (1) 
No reconstruction 
69 Stenosis Sepsis - A.B.F.B.P 10 days death 
Prosthesis renal 
ablation insufficiency 
well as the wall of the aorta, suture of the aortic stump, 
interposing the epiploon, extra-anatomic vascular e- 
construction of the lower limbs and repair of the 
intestinal lesion if required. 
The main problems involved in this type of treat- 
ment are: 
1. The strategy which must be used for vascular 
reconstruction: axillobifemoral or bipopliteal, axillo- 
femoral + crossed femorofemoral bypass, aorto or 
iliofemoral transobturator, abdominal aorta, thoracic 
aorta. 
2. Extra-anatomic reconstruction can be staged before 
excision of the infected prosthetic graft, during the 
same operation or later, sometimes in a second oper- 
ation if the degree of ischaemia permits. 
3. The choice of the type of material to be used to 
make the extra-anatomic bypass (PTFE or Dacron). 
4. Secondary rupture of the suture on the aortic stump. 
5. Infections of the extra-anatomic bypass. 
6. Long-term patency of the bypass. 
7. Mortality and morbidity. 
The incidence of infection in extra-anatomic vascular 
reconstruction varies between 13 and 20% as reported 
by many authors ,  ]2'32'33 reaching 43% in one series. BIn 
the recent multicentred retrospective AURC study, the 
infection rate for an axillofemoral bypass was only 3% 
when the material used for vascular reconstruction 
was reinforced PTFE. 36 Other authors 33 had a low rate 
of infection using extra-anatomic bypasses in standard 
PTFE (5%). Although there is no major difference 
between PTFE and Dacron in terms of long-term pat- 
ency (23 vs. 21%), the risk of infection for Dacron 
bypasses eems to be clearly higher than for PTFE (3 
VS. 15%). 36 Experimental research has demonstrated 
that PTFE is less readily colonised by infective agents 
than Dacron. 37 In our series we chose to use PTFE 
in all cases, yielding a rate of infection at 15% and a 
70% rate of long-term patency at 2 years. For some 
authors 9'38 extra-anatomic vascular reconstruction of 
the lower limbs performed before ablation of the in- 
fected prosthetic graft may be more likely to result 
in preoperative bacterial contamination through the 
bloodstream. 
Reilly and Goldstone 39 reported a 15% rate of in- 
fection for extra-anatomic bypasses when the infected 
prosthetic aortic graft was removed 3-6 days after 
vascular econstruction of the lower limbs. Other au- 
thors 34 found no statistical difference for extra-ana- 
tomic bypass infection rate, whether the bypasses were 
performed simultaneously or later than the ablation 
of the infected prosthesis. 33'35'36'3s In patients whose 
infection is limited to the prosthetic aortic graft itself, 
it would thus seem sensible, if the situation permits, 
to stage the extra-anatomic vascular econstruction of
the limbs in an aseptic operation, prior to ablation 
of the infected prosthetic graft. The second surgical 
procedure is staged a few days after vascular re- 
construction of the lower limbs, and thus has the 
advantage of limiting the period during which the 
lower limbs are submitted to ischaemia when the 
prosthesis is removed. 32'34'4°'41 It also decreases the im- 
pact of haemodynamic disturbance linked to aortic 
ligation. This procedure results in a drastic reduction 
in the number of long-term amputations (46% in sim- 
ultaneous urgery vs. 11% in staged surgery). 
Extra-anatomic bypass surgery is an operation 
which is not too aggressive and can be entirely per- 
formed under loco-regional anaesthetic with great 
benefit for these patients who have already been sub- 
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Fig. 1. Axillofemoral bypass bilateral - left anastomosis onthe 
profunda, right anastomosis on the superficial femoral rtery. 
mitted to a great deal of physical stress in terms of 
duration of surgery and anaesthesia. 42'43 These surgical 
strategies have led to a decrease in the surgical mor- 
tality rate from 26 to 13%, with a sequenced operation 
44 24 as reported by Trout et al. Kuestner et al. has also 
demonstrated a reduction in the mortality rate to 21% 
by using this type of surgical strategy for the treatment 
of secondary aortoduodenal fistulae. In our statistics, 
the surgical mortality rate was 57% for prosthetic graft 
infection and 5% for aortoduodenal fistulae; these 
results are comparable tothose reported in other ecent 
ser ies.  32'38'42 The adverse ffect of emergency operations 
compared to timely intervention is also likely to in- 
fluence the mortality rate (30% vs. 14%). 36 Over the 
last few years we have witnessed a clear reduction in 
surgical mortality compared to previous eries, 5 mainly 
due to the strategy which consists in staging the extra- 
anatomic bypass urgery before removing the infected 
prosthetic graft. In all cases, whether the treatment is 
simultaneous or sequenced, it is essential to avoid 
placing the extra-anatomic bypass vessels in the con- 
taminated area. When the inguinal regions are in- 
volved in the infectious process, it is possible to 
perform the extra-anatomic bypass in the superficial 
femoral region passing laterally around the femoral 
triangle, on the deep femoral or on the popliteal artery. 
If only one side is infected it is possible to pass through 
the obturator 4S (Fig. 1). 
Alternative pathways have been proposed as a 
source of extra-anatomic vascular econstruction such 
as the abdominal aorta 46 or the descending thoracic 
aorta. 47 They present the advantage of providing vas- 
cular reconstruction  a deeper pathway compared 
to axillofemoral bypass, avoiding the contaminated 
abdominal region with superior haemodynamic res- 
ults. This type of surgical strategy has been adopted 
by ourselves and by other authors 36 for secondary 
transformation f an axillofemoral bypass in case of 
occlusion or infection, with satisfactory results (Fig. 
2). 
Rupture of the aortic stump remains one of the main 
causes of long-term ortality in patients ubmitted to 
this type of treatment. This catastrophic emergency, 
which may be of either infective or mechanical origin, 
generally occurs in the early stage, 2 or 3 weeks after 
surgery, with variable frequency ranging from 10 to 
50% of the cases. 1'32'33'42 Reilly et al. 34 reported 25% of 
cases of rupture of the aortic stump in patients treated 
for aorto-enteric fistula, whereas there was no problem 
of aortic rupture in patients treated for uncomplicated 
prosthetic graft infection. The results of the AURC 
multicentred study 36 show that 75% of the cases of 
rupture of the aortic stump occur in patients treated for 
a secondary aortoduodenal fistula. This discrepancy 
appears to be related to the highly virulent nature of 
the germs isolated in the patients with aortoduodenal 
fistulae. The difficulty in suturing the aortic stump is 
due to the fact that it is essential to perform complete 
ablation of the infection, and the inflammatory peri- 
aortic tissue which means that the stump is difficult 
to suture. The aorta, which is fragile and inflammatory, 
is thus very susceptible to secondary complications 
and rupture. 33 Recent studies have demonstrated that 
the risk of rupture of the aortic suture decreases when 
the suture was perfect. Many techniques have been 
proposed, either a double suture using a single ply, 24 
reinforced with vein pledgets, 48reinforcing with the 
pre-vertebral fascia and also interposing a protective 
fringe of epiploon. The dual plane suture described 
by Bacourt et al. 49 seems to be the most satisfactory 
solution. On one hand this technique avoids leaving 
an anterior and posterior cul de sac on the aortic stump 
which favours renal flow and decreases the pressure 
on the aortic suture. However, as Goldstone 43states, 
if the portion of the aorta on which the suture is 
performed iscontaminated bythe infective agent, none 
of these precautions will be effective. In this case, even 
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Fig. 2. Thoracobifemoral bypass after graft infection. 
the preventive role of omentoplasty is debatable. 36In 
our series, omentoplasty was performed in all cases 
and only avoided aortic rupture in 20% of cases. In 
some cases it may be necessary to perform extended 
sub-renal and para-renal excision of the aorta to 
achieve safer suture of the stump. In such cases, re- 
construction of the renal arteries can be achieved by 
performing a splenal or hepatorenal bypass .  34 As we 
previously stated, patency of the extra-anatomic by- 
pass is not influenced by the nature of the material 
used.  36'5°'51 However, reinforced prostheses, either in 
PTFE or Dacron, unquestionably provide better pat- 
ency in terms of time than non-reinforced prostheses 
(occlusion rate 9% vs. 22%). 36 Rutherford and other 
authors  36'52 found an occlusion rate for axillofemoral 
bypasses that was clearly higher in cases of restoration 
for aortofemoral stenosis than in cases in which the 
prosthetic graft had been implanted for aneurysm of 
the abdominal aorta (38% vs. 10%). Bifemoral axillary 
bypasses would also seem to show a lower rate of 
occlusion than for unilateral bypasses for some au- 
thors, 53'~5 whereas this rate would seem to be identical 
for others. 56
Conclusion 
Technical possibilities to treat this very severe com- 
plication are many, and range from antibiotic therapy 
with maintenance of the prosthesis in moderate cases, 
to ablation of the prosthesis without immediate re- 
construction when ischaemia is not critical. Total ab- 
lation of the prosthesis combined with extra-anatomic 
bypass is the more conventional type of treatment for 
this complication. Extra-anatomic bypasses have to be 
at a certain distance from the infected foci and may 
require bilateral axillobifemoral grafts or a unilateral 
bypass plus a subpubic or subperineal shunt. Bypass 
from the abdominal or thoracic aorta to the femoral 
arteries can be used as an alternative in case of sec- 
ondary failure of an axillobifemoral graft. The re- 
construction strategy depends on the extension of the 
infection, on the state of the patient and of the predicted 
degree of ischaemia fter prosthesis ablation. 
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